LEXX vs. AVGO
Compare and contrast key facts about Lexaria Bioscience Corp. (LEXX) and Broadcom Inc. (AVGO).
Performance
LEXX vs. AVGO - Performance Comparison
Loading graphics...
LEXX vs. AVGO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LEXX Lexaria Bioscience Corp. | 26.42% | -70.62% | 68.00% | -49.19% | -38.96% | -46.12% | -34.39% | -59.14% | -44.97% | 445.16% |
AVGO Broadcom Inc. | -9.23% | 50.63% | 110.49% | 104.18% | -13.27% | 56.48% | 44.88% | 29.05% | 2.18% | 48.19% |
Fundamentals
LEXX:
$16.67M
AVGO:
$1.53T
LEXX:
-$0.55
AVGO:
$5.13
LEXX:
29.50
AVGO:
22.34
LEXX:
3.39
AVGO:
19.18
LEXX:
$522.00K
AVGO:
$68.28B
LEXX:
$522.00K
AVGO:
$46.31B
LEXX:
-$10.71M
AVGO:
$36.65B
Returns By Period
In the year-to-date period, LEXX achieves a 26.42% return, which is significantly higher than AVGO's -9.23% return.
LEXX
- 1D
- 0.00%
- 1M
- 11.59%
- YTD
- 26.42%
- 6M
- -18.13%
- 1Y
- -54.39%
- 3Y*
- -34.06%
- 5Y*
- -32.56%
- 10Y*
- —
AVGO
- 1D
- 1.29%
- 1M
- -1.47%
- YTD
- -9.23%
- 6M
- -5.59%
- 1Y
- 87.53%
- 3Y*
- 71.96%
- 5Y*
- 48.74%
- 10Y*
- 38.30%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LEXX vs. AVGO — Risk / Return Rank
LEXX
AVGO
LEXX vs. AVGO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Lexaria Bioscience Corp. (LEXX) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LEXX | AVGO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.54 | 1.82 | -2.37 |
Sortino ratioReturn per unit of downside risk | -0.35 | 2.55 | -2.89 |
Omega ratioGain probability vs. loss probability | 0.95 | 1.33 | -0.38 |
Calmar ratioReturn relative to maximum drawdown | -0.79 | 3.10 | -3.89 |
Martin ratioReturn relative to average drawdown | -1.18 | 7.61 | -8.79 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| LEXX | AVGO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.54 | 1.82 | -2.37 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.36 | 1.16 | -1.52 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.99 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.13 | 1.06 | -1.18 |
Correlation
The correlation between LEXX and AVGO is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
LEXX vs. AVGO - Dividend Comparison
LEXX has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.79%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LEXX Lexaria Bioscience Corp. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AVGO Broadcom Inc. | 0.79% | 0.70% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 3.11% | 1.87% | 1.43% | 1.13% |
Drawdowns
LEXX vs. AVGO - Drawdown Comparison
The maximum LEXX drawdown since its inception was -99.25%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for LEXX and AVGO.
Loading graphics...
Drawdown Indicators
| LEXX | AVGO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.25% | -48.30% | -50.95% |
Max Drawdown (1Y)Largest decline over 1 year | -68.59% | -28.67% | -39.92% |
Max Drawdown (5Y)Largest decline over 5 years | -93.71% | -41.15% | -52.56% |
Max Drawdown (10Y)Largest decline over 10 years | — | -48.30% | — |
Current DrawdownCurrent decline from peak | -98.89% | -23.78% | -75.11% |
Average DrawdownAverage peak-to-trough decline | -73.97% | -8.00% | -65.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 46.36% | 11.66% | +34.70% |
Volatility
LEXX vs. AVGO - Volatility Comparison
Lexaria Bioscience Corp. (LEXX) has a higher volatility of 22.55% compared to Broadcom Inc. (AVGO) at 12.62%. This indicates that LEXX's price experiences larger fluctuations and is considered to be riskier than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| LEXX | AVGO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.55% | 12.62% | +9.93% |
Volatility (6M)Calculated over the trailing 6-month period | 73.39% | 32.50% | +40.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 100.37% | 48.25% | +52.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 91.19% | 42.33% | +48.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 103.53% | 38.90% | +64.63% |
Financials
LEXX vs. AVGO - Financials Comparison
This section allows you to compare key financial metrics between Lexaria Bioscience Corp. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities